Jaguar Animal Health Shares Outstanding 2014-2018 | JAGX

Jaguar Animal Health shares outstanding from 2014 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Jaguar Animal Health Annual Shares Outstanding
(Millions of Shares)
2017 3
2016 1
2015 0
2014 0
2013 0
Jaguar Animal Health Quarterly Shares Outstanding
(Millions of Shares)
Q3 2018 12
Q2 2018 11
Q1 2018 9
Q4 2017 3
Q3 2017 4
Q2 2017 1
Q1 2017 1
Q4 2016 1
Q3 2016 1
Q2 2016 1
Q1 2016 1
Q4 2015 0
Q3 2015 1
Q2 2015 0
Q1 2015 0
Q4 2014 0
Q3 2014 0
Q2 2014 0
Q1 2014 0
Q4 2013 0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.018B $0.004B
Jaguar Health, Inc. is a natural-products pharmaceuticals company. It focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals. The company through its subsidiary Napo Pharmaceuticals Inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals. Its product pipeline consists of Mytesi(R), Canalevia(TM), Equilevia(TM) and Neonorm (TM). Jaguar Health Inc., formerly known as Jaguar Animal Health Inc., is based in San Francisco, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $40.598B 27.80
Takeda Pharmaceutical (TAK) Japan $31.372B 14.66
Grifols (GRFS) Spain $12.892B 15.73
Tilray (TLRY) United States $9.330B 0.00
Ionis Pharmaceuticals (IONS) United States $7.758B 0.00
Neurocrine Biosciences (NBIX) United States $7.713B 1701.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.676B 11.02
Nektar Therapeutics (NKTR) United States $7.187B 10.30
Loxo Oncology (LOXO) United States $7.119B 0.00
Sage Therapeutics (SAGE) United States $5.954B 0.00
United Therapeutics (UTHR) United States $4.969B 8.13
Catalent (CTLT) United States $4.883B 20.48
TESARO (TSRO) United States $4.118B 0.00
FibroGen (FGEN) United States $4.020B 0.00
Impax Laboratories (AMRX) United States $3.869B 20.57
Taro Pharmaceutical Industries (TARO) Israel $3.620B 13.40
USANA Health Sciences (USNA) United States $2.736B 23.29
Endo (ENDP) Ireland $2.086B 3.20
Heron Therapeutics (HRTX) United States $2.023B 0.00
Xencor (XNCR) United States $1.950B 0.00
Aerie Pharmaceuticals (AERI) United States $1.923B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.890B 0.00
Zogenix (ZGNX) United States $1.799B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.763B 0.00
PTC Therapeutics (PTCT) United States $1.757B 0.00
Corcept Therapeutics (CORT) United States $1.749B 25.68
Portola Pharmaceuticals (PTLA) United States $1.607B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.545B 208.83
Theravance Biopharma (TBPH) Cayman Islands $1.472B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.414B 19.90
Arrowhead Pharmaceuticals (ARWR) United States $1.311B 0.00
TherapeuticsMD (TXMD) United States $1.199B 0.00
Esperion Therapeutics (ESPR) United States $1.141B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.112B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.976B 0.00
Tricida (TCDA) United States $0.928B 0.00
ImmunoGen (IMGN) United States $0.775B 0.00
Radius Health (RDUS) United States $0.718B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.628B 0.00
ChemoCentryx (CCXI) United States $0.613B 48.56
Siga Technologies (SIGA) United States $0.590B 0.00
Karyopharm Therapeutics (KPTI) United States $0.588B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.588B 0.00
Collegium Pharmaceutical (COLL) United States $0.523B 0.00
Flexion Therapeutics (FLXN) United States $0.493B 0.00
Forty Seven (FTSV) United States $0.490B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.455B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.448B 26.39
GlycoMimetics (GLYC) United States $0.439B 0.00
Odonate Therapeutics (ODT) United States $0.409B 0.00
ArQule (ARQL) United States $0.385B 0.00
CASI Pharmaceuticals (CASI) United States $0.361B 0.00
Xeris Pharmaceuticals (XERS) United States $0.357B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.355B 0.00
Akebia Therapeutics (AKBA) United States $0.345B 0.00
Majesco Entertainment (PTE) United States $0.345B 0.00
KalVista Pharmaceuticals (KALV) United States $0.344B 0.00
Concert Pharmaceuticals (CNCE) United States $0.325B 0.00
Dermira (DERM) United States $0.304B 0.00
Lannett Co Inc (LCI) United States $0.304B 2.63
OptiNose (OPTN) United States $0.290B 0.00
Minerva Neurosciences (NERV) United States $0.284B 0.00
Aclaris Therapeutics (ACRS) United States $0.281B 0.00
Depomed (ASRT) United States $0.270B 10.05
Verrica Pharmaceuticals (VRCA) United States $0.269B 0.00
Tapimmune (MRKR) United States $0.267B 0.00
Mast Therapeutics (SVRA) United States $0.264B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.264B 0.00
Translate Bio (TBIO) United States $0.262B 0.00
IMV INC (IMV) Canada $0.254B 0.00
Tyme Technologies (TYME) United States $0.254B 0.00
Aldeyra Therapeutics (ALDX) United States $0.233B 0.00
Opexa Therapeutics (ACER) United States $0.232B 0.00
Dova Pharmaceuticals (DOVA) United States $0.213B 0.00
Affimed (AFMD) Germany $0.212B 0.00
MEI Pharma (MEIP) United States $0.206B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.205B 0.00
TAIWAN LIPOSOME (TLC) Taiwan $0.201B 0.00
Aratana Therapeutics (PETX) United States $0.195B 0.00
Aquestive Therapeutics (AQST) United States $0.186B 0.00
Galectin Therapeutics (GALT) United States $0.184B 0.00
Zafgen (ZFGN) United States $0.175B 0.00
Recro Pharma (REPH) United States $0.167B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.164B 0.00
Ocular Therapeutix (OCUL) United States $0.163B 0.00
Molecular Templates (MTEM) United States $0.162B 0.00
Calithera Biosciences (CALA) United States $0.161B 0.00
Rafael Holdings (RFL) United States $0.154B 0.00
Nature's Sunshine Products (NATR) United States $0.154B 0.00
Jounce Therapeutics (JNCE) United States $0.152B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.151B 0.00
Neon Therapeutics (NTGN) United States $0.148B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.145B 0.00
ElectroCore (ECOR) United States $0.144B 0.00
Redhill Biopharma (RDHL) Israel $0.143B 0.00
Ardelyx (ARDX) United States $0.143B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.142B 0.00
Adherex Technologies (FENC) United States $0.138B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.135B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.134B 0.00
MediWound (MDWD) Israel $0.120B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.116B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.112B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.110B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.109B 0.00
Champions Oncology (CSBR) United States $0.108B 0.00
ProNAi Therapeutics (SRRA) Canada $0.102B 0.00
DURECT (DRRX) United States $0.100B 0.00
Aptorum Group (APM) China $0.096B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.090B 0.00
Natural Alternatives (NAII) United States $0.082B 8.06
Iterum Therapeutics (ITRM) Ireland $0.080B 0.00
Nivalis Therapeutics (ALPN) United States $0.078B 0.00
Cardiome Pharma (CORV) Canada $0.076B 0.00
CTI BioPharma (CTIC) United States $0.075B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.074B 0.00
Infinity Pharmaceuticals (INFI) United States $0.073B 0.00
KemPharm (KMPH) United States $0.071B 0.00
Immune Design (IMDZ) United States $0.070B 0.00
Neos Therapeutics (NEOS) United States $0.067B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.066B 0.00
Achaogen (AKAO) United States $0.065B 0.00
Otonomy (OTIC) United States $0.062B 0.00
Avenue Therapeutics (ATXI) United States $0.060B 0.00
BioLineRx (BLRX) Israel $0.059B 0.00
Melinta Therapeutics (MLNT) United States $0.058B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.053B 0.00
Genocea Biosciences (GNCA) United States $0.052B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.052B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.050B 0.00
Forward Pharma (FWP) Denmark $0.050B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.050B 0.00
ContraFect (CFRX) United States $0.047B 0.00
Mannatechorporated (MTEX) United States $0.046B 0.00
Capnia (SLNO) United States $0.039B 0.00
SCYNEXIS (SCYX) United States $0.036B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.035B 0.00
Heat Biologics (HTBX) United States $0.034B 0.00
Lipocine (LPCN) United States $0.034B 0.00
Novan (NOVN) United States $0.034B 0.00
ProPhase Labs (PRPH) United States $0.034B 0.00
Trillium Therapeutics (TRIL) Canada $0.027B 0.00
IsoRay (ISR) United States $0.026B 0.00
ESSA Pharma (EPIX) Canada $0.024B 0.00
Can-Fite Biopharma (CANF) Israel $0.023B 0.00
PharmAthene (ALT) United States $0.023B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.023B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.022B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.021B 0.00
Citius Pharmaceuticals (CTXR) United States $0.020B 0.00
NanoViricides (NNVC) United States $0.020B 0.00
Biomerica (BMRA) United States $0.019B 0.00
Xenetic Biosciences (XBIO) United States $0.019B 0.00
Pain Therapeutics (PTIE) United States $0.019B 0.00
Cyanotech (CYAN) United States $0.018B 0.00
HANCOCK JAFFE (HJLI) United States $0.018B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
Aviragen Therapeutics (VXRT) United States $0.016B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.016B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.016B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.015B 0.00
Shineco (TYHT) China $0.013B 1.48
Onconova Therapeutics (ONTX) United States $0.013B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.011B 0.00
Skyline Medical (AIPT) United States $0.011B 0.00
Regulus Therapeutics (RGLS) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.008B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.007B 0.00
Apricus Biosciences (APRI) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Aradigm (ARDM) United States $0.006B 0.00
Midatech Pharma (MTP) United Kingdom $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.005B 0.00
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.004B 0.00
Intellipharmaceutics (IPCI) Canada $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
AGEX THERAPEUTC (AGE) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00